Michael Lilly to Leukemia, Myeloid
This is a "connection" page, showing publications Michael Lilly has written about Leukemia, Myeloid.
Connection Strength
0.108
-
Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathway. Leukemia. 2008 Jan; 22(1):138-46.
Score: 0.075
-
Inhibition of leukemic cell growth by the protein kinase C activator bryostatin 1 correlates with the dephosphorylation of cyclin-dependent kinase 2. Cancer Res. 1995 Sep 01; 55(17):3716-20.
Score: 0.032